Repeatable Battery for the Assessment of Neuropsychological Status Update
RBANS Update
A brief individually administered battery to measure cognitive decline or improvement across five domains in ages 12 to 89 years 11 months- Publication date:
- 2012
- Completion time:
- 30 minutes
- Administration:
- Individual; Q-interactive administration and scoring; Q-global scoring and reporting; or manual scoring
- Age range:
- 12 to 89 years 11 months
- Qualification level:
- B
The RBANS Update provides a brief, individually administered battery to measure cognitive decline or improvement across 5 domains:
- Immediate Memory – List learning and Story Memory
- Visuospacial/Constructional – Figure Copy and Line Orientation
- Language – Picture naming and Semantic Fluency
- Attention – Digit Span and Coding
- Delayed Memory – List Recall, List Recognition, Story Memory, and Figure Recall
This instrument is used by clinicians and neuropsychologists to help:
- Screen for deficits in acute-care settings
- Track recovery during rehabilitation
- Track progression of neurological disorders
- Screen for neurocognitive status in adolescents
Features & Benefits
RBANS Update provides significant improvements, including:
- Downward age extension to 12:0 years
- Subtest scores now available in addition to index scores
- Manual updates, including information on adolescents and review of RBANS-specific research conducted since original publication(1998)
Parallel Forms
Ideal for measuring change over time, RBANS Update offers four parallel forms. Form A offers a single set of norms based on age, gender, race, education, and geographic region with equating studies and adjustments for Forms B-D.
RBANS Update can also be used in a variety of ways including:
- As a stand-alone “core” battery for the detection and characterisation of dementia in the elderly
- As a neuropsychological “screen battery” when lengthier assessments are either impractical or inappropriate
- For repeat evaluations when an alternate form is needed to control for content practice effects
- In Clinical Trials to identify inclusion/exclusion criteria as well as efficacy and cognitive side effects
Setting-Specific Information
Although RBANS Update was originally developed with a primary focuson assessment of dementia, special group studies are available for Alzheimer’s Disease, Vascular Dementia, HIV Dementia, Huntington’s Disease, Parkinson’s Disease, Depression, Schizophrenia, and Closed Head Injury. With the additional collection of adolescent data, RBANS Update also has utility as a screener for neurocognitive status in younger patients as well. Finally, RBANS UPDATE has been used in a number of Clinical Trials and is available in over 20 languages.
Tests in the RBANS Update harness the processing capacities of Q-interactive to provide new, more dynamic, cognitively demanding tasks that are unable to be delivered and scored with fidelity in a traditional paper format.
Test Components
Required items for administering RBANS Update on Q-interactive:
| 015-8009-673 |
Digital Assessment LibraryLearn more about our all access pass to digital assessments |
Support |
Existing Users
If you have an active Q-interactive or Digital Assessment Library (DAL) license, RBANS Update will be automatically added to your account.
Related Items
